Faculty and Topics

• Eric Bershad, MD Assistant Professor of Neurology Baylor College of Medicine
  Stroke Syndromes, Intracranial Hemorrhage
• Erik Ensrud, MD† Director, Neuromuscular Disease St. Luke's Rehabilitation Institute, Spokane, WA
  Anterior Horn Cell, Myopathies, Neuromuscular Junction, Focal Neuropathies, MS and Demyelinating Diseases, Peripheral Neuropathies
• Ajay Gupta, MD Assistant Professor of Neurology Cleveland Clinic Foundation
  Neurocutaneous Disorders, Neurogenetics, Neurochemistry and Neurotransmitters, Epilepsy, Sleep and EEG, Seizure and Status Emergency
• Joseph Kass, MD, JD Associate Professor of Neurology Baylor College of Medicine
  Infections and AIDS
• Simon Ovanessian, MD Assistant Professor in Psychiatry New York Medical College
  Aphasia, Ataxia and Localization, Headache Disorders, Inborn Errors of Metabolism, Dementia
• Chethan Rao, MD Assistant Professor of Neurology Baylor College of Medicine
  Spinal Cord Compression, Neurological Emergencies, Acute Stroke, Stroke Prevention
• Olga Waln, MD Assistant Professor of Clinical Neurology Weill Cornell Medical College
  Movement Disorders

Faculty, Planner, and Reviewer Disclosure Declaration

In compliance with the Standards, Guidelines, and Ethical opinions of the ACCME, AAMC and AMA, The Osler Institute requires that anyone with input into the planning or presentation of Continuing Medical Education activities provided or jointly-provided by The Osler Institute must disclose to the program audience any relevant financial relationships with companies or organizations about whose products or services they are discussing in their presentations.

• The following faculty/planners/reviewers disclosed a relevant financial relationship(s).
• Ajay Gupta, MD - Consultant for Lundbeck, Inc. and Mallinckrodt Pharmaceutica
• Joseph Kass, MD, JD - PI for studies funded by Merck, Genentech, and Sanofi
• Simon Ovanessian, MD - Speaker for Alkermes and Otsuka Pharmaceutical
• The following faculty/planners/reviewers listed no relevant financial relationship(s) to disclose.
• Eric Bershad, MD
• Erik Ensrud, MD†
• Brian Krause, MD*
• Chethan Rao, MD
• Olga Waln, MD
• Angie Kowitz†
• Joseph Selliken, MD†
• Michael Stewart†
• Sally Schuette, PhD†
  
  Copies of the Faculty Disclosure Forms are available upon request.
  † Program Planning Committee
  * Reviewer if Applicable

Learning Objectives

At the conclusion of this course each participant will be able to:

• Recognize and discuss all major neurological disorders and important variants
• Recognize and discuss neurologic complications of systemic diseases
• Discuss important aspects of critical care and trauma management as relates to brain injuries and neuromuscular emergencies
• Implement appropriate primary and secondary stroke prevention strategies
• Describe developmental disorders and scientific underpinnings
• Distinguish abnormal behavioral and personality changes
• Discuss use of appropriate psychopharmacology agents for all major neurologic disorders and important interactions
• Identify and plan treatment for alcoholism and substance abuse Identify and distinguish between altered states of consciousness and memory disorders